Why the study?
Despite evidence showing a close relationship between (P)RR and autophagy, the influence of autophagy inhibition on soluble (P)RR expression in cancer cells remained unclear.
Does autophagy inhibition increase soluble (pro)renin receptor protein levels in cultured cancer cells?
Does autophagy inhibition increase soluble (pro)renin receptor protein levels in cultured cancer cells?
Autophagy inhibition increases the accumulation and secretion of soluble (pro)renin receptor protein in cultured cancer cells, likely due to reduced degradation in intracellular vesicles.
Autophagy inhibition may raise soluble (P)RR in cancer cells; hypothesis-generating and requires in vivo validation before any clinical consideration.
-ATPase. There is accumulating evidence that shows close relationship between (P)RR and autophagy. Soluble (P)RR consisting of the extracellular domain of (P)RR is generated from (P)RR by proteolytic enzymes. The aim of the present study was to clarify the influence of autophagy inhibition on soluble (P)RR expression in cancer cells. Autophagy was inhibited by treatment of bafilomycin A1 or chloroquine in MCF-7 and A549 cells for 72 hr. Western blot analysis showed that protein levels of soluble (P)RR were markedly elevated by autophagy inhibition, whereas no noticeable increases were observed in full-length (P)RR. Secretion of soluble (P)RR into the medium was increased dose-dependently by bafilomycin A1 or chloroquine. Autophagy inhibition was confirmed by enhanced accumulation of autophagy-related proteins, LC3, p62 and LAMP1 in intracellular vesicles. Increased amount of soluble (P)RR by autophagy inhibition was decreased by site-1 protease inhibitor, whereas no noticeable increase in site-1 protease immunoreactivity was observed in cells with autophagy inhibition by immunocytochemistry. These findings suggest that soluble (P)RR protein accumulates by autophagy inhibition, possibly because of the reduced degradation of soluble (P)RR in the intracellular vesicles during autophagy inhibition.
No takes yet. Share an insight, caveat, or question.
Endo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: